Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IBT Vaccines
Rockville, Maryland, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
IBT Vaccines, a wholly owned subsidiary of Integrated Biotherapeutics, is advancing IBT‑V02, a heptavalent toxoid vaccine targeting multiple Staphylococcus aureus toxins for prevention of MRSA-related post-surgical and recurrent skin and soft tissue infections; as of the latest public reports, IBT‑V02 is in late preclinical/IND‑enabling development with funding support from CARB‑X and Novo Holdings’ REPAIR Impact Fund, with first-in-human trials planned but not yet reported as completed.[3][7]
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineToxoid vaccineBiologic
- Industry
- Biotech
02
Partnerships
Novo Holdings REPAIR Impact Fund (funding partnership for IBT‑V02)[7]CARB-X (funding and development support for IBT‑V02)[3][7]National Institute of Allergy and Infectious Diseases (NIAID) – via parent company programs that support IBT‑V02 development[1][3][7]
Beyond the preview
Go deeper on IBT Vaccines.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IBT Vaccines.